Compared to the placebo, patients treated with Kisunla had a 35% slower cognitive and functional decline at 18 months of ...

Several Alzheimer’s patients in Fresno became some of the first in the nation to receive a new drug just approved by the FDA.

Doctors said the drug Kisunla is the first drug to be approved by the FDA for Alzheimer’s in more than a decade giving hope ...

FRESNO, Calif. (KFSN) -- A long-time Fresno doctor is part of a ground-breaking treatment in the fight against Alzheimer's.

Alzheimer’s drug, donanemab (marketed as Kisunla), could be rejected for use by the National Health Service (NHS) in Britain, ...

Several people in fresno were among the first in the nation to receive a new treatment for alzheimer's disease.Now patients ...

New AI software promises to make diagnosing dementia quicker and more accurate, helping doctors provide timely and effective ...

FRESNO, Calif. (KFSN) -- A long-time Fresno doctor is part of a ground-breaking treatment in the fight against Alzheimer's. In July, the FDA approved Kisunla for people with mild cognitive ...

Kisunla (donanemab-azbt) is a prescription drug that’s used to treat Alzheimer’s disease in adults. Kisunla is given as an intravenous (IV) infusion by a doctor or other healthcare professional.

But Eli Lilly got there first. With the FDA's approval in early July of Kisunla, its new medicine for Alzheimer's developed ...

Shortly after a U.K. watchdog declined to endorse Biogen's ( NASDAQ: BIIB) Alzheimer's drug Leqembi for use in the country's ...